Hepatitis - Technical work
The WHO Department leads the global effort to end the epidemics of HIV, tuberculosis (TB), hepatitis, and sexually transmitted infections (STIs), ensuring that every person has equitable access to highest-quality people-centred scientific evidence and services, regardless of who they are or where they live.
About us

Treatment of hepatitis C virus infection

WHO estimates that in 2015, 71 million people were living with chronic hepatitis C virus (HCV) infection worldwide, and 399 000 died from cirrhosis or hepatocellular carcinoma caused by HCV infection.

In 2013–2014, a new class of oral medicines called direct-acting antivirals revolutionized HCV treatment. With a cure rate of over 95%, direct-acting antivirals have fewer side effects than previous, less effective therapies, and patients can be fully cured with an 8–12 week course of the medicines.